Ubrogepant

Brand name: Ubrelvy

Rank #157 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$100.6M

Total Cost

Share:

75,781

Total Claims

$100.6M

Total Cost

2,545

Prescribers

$1,327

Cost per Claim

8,589

Beneficiaries

78,499

30-Day Fills

$40K

Avg Cost/Provider

30

Avg Claims/Provider

Share of Medicare Part D Spending

0.04%

of total Medicare Part D spending

$100.6M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $100.6M total

🔎 Data Overview

💰

At $1,327 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $11,707 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Ubrogepant

#ProviderSpecialtyLocationClaimsCost
1Farhad Kadkhodaei ElyaderaniNeurologyBronx, NY356$626K
2Robert PearlmanNeurologyBirmingham, AL491$615K
3Ernesto AlonsoNeurologyLake City, FL244$586K
4Dmitriy GrinshpunNeurologyBrooklyn, NY287$551K
5Fernando Gonzales-PortilloInternal MedicineOrlando, FL384$550K
6Melissa JohnsonNurse PractitionerAshland, KY265$344K
7Michael AmoashiyNeurologyBrooklyn, NY177$335K
8Naga Lakshmana NidadavoluNeurologySaint Cloud, FL229$326K
9Casilda BalmacedaNeurologyNew York, NY223$303K
10Alicia DuyvejonckNurse PractitionerDavenport, IA187$300K
11Susan SergentPhysician AssistantLexington, KY204$295K
12Sheila Anne BobisPhysician AssistantRiverside, CA216$289K
13Marie Labadie-DegennaroNurse PractitionerTampa, FL139$282K
14Stephanie KhanNurse PractitionerForest Hills, NY87$278K
15Daniel Nohra RevillaNeurologyOrlando, FL167$259K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
154Divalproex Sodium (Divalproex Sodium)$103.4M1,921,840
155Nilotinib Hcl (Tasigna)$100.9M6,308
156Quetiapine Fumarate (Quetiapine Fumarate)$100.9M3,820,737
157Ubrogepant (Ubrelvy)$100.6M75,781
158Darunavir/Cobicistat (Prezcobix)$99.7M38,374
159Tocilizumab (Actemra)$99.5M24,891
160Omalizumab (Xolair)$98.9M30,451

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology